American Recovery and Reinvestment Act (ARRA) Supplemental Funding for Reaching More Children and Adults | Apply Online

FAQs: ARRA Supplemental Funding for Reaching More Children and Adults (CDC)

What is the ARRA Supplemental Funding for Reaching More Children and Adults?

This is a CDC funding opportunity created under the American Recovery and Reinvestment Act (ARRA) to rapidly expand vaccination coverage for both children and adults. The focus is on increasing immunization against vaccine-preventable diseases by supporting activities that help reach more people quickly and measurably.

What is the main goal of this funding opportunity?

The purpose is to increase the number of children and adults vaccinated against vaccine-preventable diseases. The CDC framed it as a fast, high-impact effort that relies on existing immunization program infrastructure rather than building new systems from scratch.

Why was this funding issued as an ARRA (Recovery Act) initiative?

The opportunity reflects ARRA's emphasis on time-sensitive supplemental investments that accelerate public health work. The program design is intended to support immediate execution and measurable expansion of vaccination efforts using established, functioning programs.

Who administers this grant opportunity?

The administering agency is the Centers for Disease Control and Prevention (CDC).

Who is eligible to apply?

Eligibility is limited to the 64 current grantees already funded under RFP IP08 803. Only those existing recipients were eligible to apply for this supplemental funding.

Why is eligibility limited to current grantees under RFP IP08 803?

The stated rationale is that these organizations already have the necessary immunization infrastructure and operational experience to carry out the required activities successfully. This structure allows ARRA funds to be deployed through proven channels with minimal startup delay.

How many awards were expected to be made?

The announcement indicates 64 awards.

How much funding was available?

The announcement states that approximately $78,000,000 would be available in fiscal year 2009 to fund 64 awards. It also lists an estimated total funding level of $98,000,000.

Why are there two different funding totals listed ($78,000,000 and $98,000,000)?

The summary record lists both an FY2009 availability figure (approximately $78,000,000) and an estimated total funding level ($98,000,000). The provided information does not explain the difference, and the full announcement would typically clarify how these totals relate (for example, across periods or components).

What was the minimum and maximum award size?

The award floor was $180,000 and the award ceiling was $12,000,000. This wide range suggests awards were meant to scale based on factors such as program size, population served, proposed activities, and recipient capacity to deliver increased vaccination results.

Is cost sharing or matching required?

No. The announcement specifies that no cost sharing or matching was required, which reduces barriers to deploying funds quickly for expanded service delivery and program operations.

What types of activities were expected to be supported?

The summary indicates the intent was to expand proven interventions to increase vaccination coverage. Examples mentioned include outreach, reminder and recall systems, clinic and provider support, public messaging, vaccine access strategies, and other activities that remove barriers to immunization and improve delivery capacity.

Is this funding intended to build new immunization systems?

No. The CDC framed this as using established immunization infrastructure to reach more people quickly and measurably, rather than creating new systems from scratch.

What is the opportunity category and funding instrument?

The opportunity category and instrument type are both listed as "Other." The activity category is explicitly tied to the Recovery Act, indicating the funds are part of ARRA supplemental public health spending.

When was the opportunity posted?

The opportunity was posted on June 2, 2009.

What was the application deadline?

The application deadline (original and current closing date) was July 2, 2009.

What time were applications due on the closing date?

Applications were due by 5:00 p.m. Eastern Time on July 2, 2009.

How long was the application window?

Based on the posted date (June 2, 2009) and closing date (July 2, 2009), the application window was approximately one month, consistent with the urgency typical of ARRA funding.

When was the opportunity archived?

The archive date was August 1, 2009, indicating the opportunity was open for a limited window and then formally closed.

Why does the record show a creation date in 2010 if the deadline was in 2009?

The record lists a creation date of January 29, 2010, which appears to reflect when the opportunity record was created or entered into a system rather than when applications were accepted. The operational dates for submission remained in 2009.

Where can applicants find detailed requirements and expectations?

The summary notes an additional information link instructing readers to click the full announcement at the top of the page. Detailed requirements such as allowable activities, reporting expectations, and performance measures would be contained in the full FOA document, not the summary record.

Who should be contacted for help accessing the full announcement electronically?

The contact listed for help accessing the full announcement electronically is PGO TIMS at 770-488-2700. A general email is referenced but not specified in the provided information.

Does this opportunity support both child and adult vaccination?

Yes. The opportunity is explicitly designed to expand vaccination coverage for both children and adults.

Is this opportunity an add-on to an existing CDC immunization program?

Yes. Because only current grantees under RFP IP08 803 could apply, this operated as supplemental (add-on) funding to an existing CDC immunization funding stream, enabling rapid deployment through established programs.